Pancreatic Cancer Research

ResearcherGarvan Institute of Medical ResearchNo recent work listed

Marc Giry-Laterrière

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9043-8935; OpenAlex author ID A5025069644. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2015: 3 papers · 2016: 1 paper · 2017: 2 papers · 2018: none · 2019: none · 2020: 1 paper

Papers 7

  1. HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer. Co-author DOI 10.1016/j.celrep.2020.107625↗
  2. Hypermutation In Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2016.09.060↗
  3. Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis. Co-author DOI 10.1126/scitranslmed.aai8504↗
  4. Genomic analyses identify molecular subtypes of pancreatic cancer. Co-author DOI 10.1038/nature16965↗
  5. Whole genomes redefine the mutational landscape of pancreatic cancer. Co-author DOI 10.1038/nature14169↗
  6. SOX9 regulates ERBB signalling in pancreatic cancer development. Co-author DOI 10.1136/gutjnl-2014-307075↗
  7. Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas. Co-author DOI 10.2174/1568009615666150512102957↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andreia V. Pinho · 2 shared papers, 2015 · strength 0.11
  2. Ilse Rooman · 2 shared papers, 2015 · strength 0.11
  3. Nils Eling · 1 shared paper, 2015 · strength 0.06
  4. Lorraine A. Chantrill · 1 shared paper, 2015 · strength 0.06
  5. Marina Pajic · 1 shared paper, 2015 · strength 0.04
  6. Sean Michael Grimmond · 1 shared paper, 2015 · strength 0.04
  7. Mark J. Cowley · 1 shared paper, 2015 · strength 0.04
  8. Adrien Grimont · 1 shared paper, 2015 · strength 0.04
  9. Patrick Jacquemin · 1 shared paper, 2015 · strength 0.04
  10. Andrew Victor Biankin · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.